bf/NASDAQ:LXRX_icon.jpeg

NASDAQ:LXRX

Lexicon Pharmaceuticals, Inc.

  • Stock

USD

Last Close

1.43

06/11 22:31

Market Cap

589.23M

Beta: 1.33

Volume Today

4.08M

Avg: 593.73K

PE Ratio

−3.21

PFCF: −3.75

OverviewFinancialsAPI

    Description

    Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.50.511.522018-11-012020-04-272022-02-282023-08-032024-11-06

    Revenue (Estimate*)

    50M100M150M200M250M300M2018-11-012020-04-272022-02-282023-08-032024-11-06

    *Estimate based on analyst consensus